Roche expands Boston research footprint with new center

Roche is expanding its Boston-area presence with a new research center, signaling continued investment in biotech innovation. The move follows a gene therapy approval for Sanfilippo syndrome and mixed results for Xenon Pharma, indicating active sector developments. This expansion underscores Roche's strategic focus on the US biotech hub.